Evidence for separation of HCV subtype 1a into two distinct clades
暂无分享,去创建一个
[1] F. Crick. Codon--anticodon pairing: the wobble hypothesis. , 1966, Journal of molecular biology.
[2] M. Nei,et al. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.
[3] Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[4] E. Holmes,et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. , 1993, The Journal of general virology.
[5] R. Esteban,et al. Epidemiology of hepatitis C virus infection. , 1993, Journal of hepatology.
[6] M. Sakamoto,et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. , 1993, The Journal of general virology.
[7] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[8] A. Prince,et al. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. , 1994, Virology.
[9] N. Enomoto,et al. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. , 1994, Virology.
[10] R. Purcell,et al. Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.
[11] D. Mindell,et al. Positive selection and rates of evolution in immunodeficiency viruses from humans and chimpanzees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] N Enomoto,et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.
[13] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Purcell,et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. , 1996, Virology.
[15] B. Korber,et al. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease , 1997, Journal of virology.
[16] H. Thomas,et al. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients , 1998, Hepatology.
[17] A. Kwong,et al. Hepatitis C virus NS3/4A protease. , 1997, Antiviral research.
[18] Z. Yang,et al. Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. , 1998, Molecular biology and evolution.
[19] A. Zibert,et al. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection. , 1999, Journal of hepatology.
[20] C. Rice,et al. Identification of the Major Phosphorylation Site of the Hepatitis C Virus H Strain NS5A Protein as Serine 2321* , 1999, The Journal of Biological Chemistry.
[21] A. Siddiqui,et al. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. , 2000, The Journal of biological chemistry.
[22] S. Zeuzem. Hepatitis C virus: kinetics and quasispecies evolution during anti-viral therapy. , 2000, Forum.
[23] H J Alter,et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.
[24] Zhenming Xu,et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift , 2001, The EMBO journal.
[25] D. Stump,et al. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. , 2001, RNA.
[26] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.
[27] M. Unemo,et al. Comparison of Serologic and Genetic porB-Based Typing of Neisseria gonorrhoeae: Consequences for Future Characterization , 2003, Journal of Clinical Microbiology.
[28] P. Mavromara,et al. Two Alternative Translation Mechanisms Are Responsible for the Expression of the HCV ARFP/F/Core+1 Coding Open Reading Frame* , 2003, Journal of Biological Chemistry.
[29] P. Simmonds,et al. Genetic diversity and evolution of hepatitis C virus--15 years on. , 2004, The Journal of general virology.
[30] Edward C. Holmes,et al. High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression , 2004, Journal of Virology.
[31] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[32] Todd M. Allen,et al. Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes1 , 2005, The Journal of Immunology.
[33] S. Das,et al. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site , 2006, Archives of Virology.
[34] C. Bréchot. Hepatitis C virus , 1996, Digestive Diseases and Sciences.
[35] Mark J. Schreiber,et al. Establishment of a pipeline to analyse non-synonymous SNPs in Bos taurus , 2006, BMC Genomics.
[36] T. Berg,et al. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. , 2006, Gastroenterology.
[37] H. Conjeevaram,et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. , 2006, Gastroenterology.
[38] R. Striker,et al. Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B , 2007, Hepatology.
[39] A. Kwong,et al. Phenotypic and Structural Analyses of Hepatitis C Virus NS3 Protease Arg155 Variants , 2007, Journal of Biological Chemistry.
[40] Todd M. Allen,et al. Viral Sequence Evolution in Acute Hepatitis C Virus Infection , 2007, Journal of Virology.
[41] Rick L. Stevens,et al. National Institute of Allergy and Infectious Diseases Bioinformatics Resource Centers: New Assets for Pathogen Informatics , 2007, Infection and Immunity.
[42] M. Nei,et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.
[43] C. Rice,et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. , 2007, Gastroenterology.
[44] Hengli Tang,et al. Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro , 2007, Journal of Virology.
[45] Tara L. Kieffer,et al. Telaprevir and pegylated interferon–alpha‐2a inhibit wild‐type and resistant genotype 1 hepatitis C virus replication in patients , 2007, Hepatology.
[46] Milton W. Taylor,et al. Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy , 2007, Journal of Virology.
[47] X. Tong,et al. Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN alpha-2b using TaqMan mismatch amplification mutation assay. , 2008, Journal of virological methods.
[48] A. Moya,et al. Genetic variability in hepatitis C virus and its role in antiviral treatment response , 2007, Journal of viral hepatitis.
[49] A. Moya,et al. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment , 2008, Journal of medical virology.
[50] R. Aurora,et al. Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy , 2008, PloS one.
[51] A. Fomsgaard,et al. The evolution of human influenza A viruses from 1999 to 2006: A complete genome study , 2008, Virology Journal.
[52] B. McMahon,et al. Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. , 2008, Virology.
[53] Todd M. Allen,et al. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment‐naïve patients , 2008, Hepatology.
[54] O. Pybus,et al. Evolution and dispersal of St. Louis encephalitis virus in the Americas. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.